In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

Teva Pharmaceuticals (TEVA) and Alvotech (ALVO) announced the availability of SELARSDI injection in the U.S., a biosimilar to Stelara for the ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

The FDA has approved biosimilars for: While many psoriasis medications come as injections, apremilast is a psoriasis treatment that comes as a pill. If you can’t take any of these medications or ...

EQS-News: Benzinga / Key word (s): Science Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And ...

Injections should not be administered into psoriasis skin lesions. Signs and symptoms of infection should be reviewed with the patient. Make sure patients understand that an ISR will resolve and ...

There were 503 participants at baseline who had a Psoriasis Area and Severity Index ... were COVID-19 and nasopharyngitis. Notably, no injection site reactions or systemic hypersensitivity ...

Local companies are developing technologies that they hope could replace a painful poke with something that feels more like ...

Biologics are known to be quite effective for managing moderate to severe psoriasis. Biologics are given by injection or infusion Biologics are administered either by injection or infusion.